Product
Oxaliplatin + Leucovorin + 5-Fluorouracil
1 clinical trial
2 indications
Indication
Colon CancerIndication
Stage III Colon CancerClinical trial
Phase II Open-Label Trial of Neoadjuvant Atezolizumab in Combination With CAPEOX for Resectable Non-Metastatic Proficient Mismatch Repair (PMMR) Colon CancerStatus: Not yet recruiting, Estimated PCD: 2026-09-01